<!DOCTYPE html>
<html lang="en">
    

    <head>
        <link rel="preconnect" href="https://fonts.googleapis.com">
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link href="https://fonts.googleapis.com/css2?family=Press+Start+2P&family=Roboto+Condensed:wght@300&family=VT323&display=swap" rel="stylesheet"> 
        <link rel="stylesheet" href="/src/resource/css/basic.css">
    
    </head> 
    <body  >   
        <p dir="ltr"><span>Cerebral Manifestations of Ergotism</span></p>
<p dir="ltr"><span>Report of a Case and Review of the Literature</span></p>
<p dir="ltr"><span>HOWARD J. SENTER, M.D.,* ABRAHAM N. LIEBERMAN, M.D.t</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>AND RICHARD PINTO, M.D.$</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>SUMMARY A patient with diffuse and focal cerebral dysfunction</span></p>
<p dir="ltr"><span>was found to have absent peripheral pulses. Cerebral angiography</span></p>
<p dir="ltr"><span>revealed evidence of an arteritis with bilateral high grade carotid</span></p>
<p dir="ltr"><span>stenosis. When there was no laboratory confirmation of the arteritis,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>an iatrogenic etiology (ergotism) was suspected. This was later con-</span></p>
<p dir="ltr"><span>firmed by the patient. The pertinent literature on ergotism is</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>reviewed, and it is emphasized that ergotism may develop in patients</span></p>
<p dir="ltr"><span>on therapeutic doses of the drug.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>THE TOXIC EFFECTS OF ERGOT on the peripheral</span></p>
<p dir="ltr"><span>vasculature are well recognized, but the toxic effects of ergot</span></p>
<p dir="ltr"><span>on the cerebral vasculature are less well known. This paper</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>describes the neurological and angiographical manifes-</span></p>
<p dir="ltr"><span>tations of ergotism in a patient, and reviews the pertinent</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>literature.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Case Report</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>A 36-year-old, right-handed white woman awoke con-</span></p>
<p dir="ltr"><span>fused on the morning of admission, and had a left</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>hemiparesis.</span></p>
<p dir="ltr"><span>At age 17, the patient had migraine headaches</span></p>
<p dir="ltr"><span>characterized by a prodrome of scintillating scotomata</span></p>
<p dir="ltr"><span>followed by a right or left hemicranial headache terminated</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>by nausea. For 20 years she had been taking ergotamine tar-</span></p>
<p dir="ltr"><span>trate suppositories (Cafergot&reg;) with good symptomatic</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>relief. For the three weeks prior to admission she had been</span></p>
<p dir="ltr"><span>under unusual emotional stress and noted a sharp increase in</span></p>
<p dir="ltr"><span>the frequency of her headaches. However, she denied taking</span></p>
<p dir="ltr"><span>more than half a suppository (1 mg of ergotamine) a day.</span></p>
<p dir="ltr"><span>One week prior to admission she consulted a physician</span></p>
<p dir="ltr"><span>because of leg cramps. He found absent pulses below the</span></p>
<p dir="ltr"><span>groin and, unaware of the history of ergot usage, prescribed</span></p>
<p dir="ltr"><span>a vasodilating agent, nylidrin hydrochloride (Arlidin&reg;),</span></p>
<p dir="ltr"><span>without symptomatic relief. Nylidrin was discontinued a few</span></p>
<p dir="ltr"><span>days later. On the day prior to admission, the patient was</span></p>
<p dir="ltr"><span>unusually drowsy and that night had difficulty climbing</span></p>
<p dir="ltr"><span>stairs and getting into bed. She awoke at 6 A.M. on the day of</span></p>
<p dir="ltr"><span>admission and was unable to move her left side.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>&bull;Resident, tAssistant Professor, Department of Neurology, ^Fellow, Department of Neuroradiology, New York University School of Medicine, 560 First Avenue, New York, New York 10016.</span></p>
<p dir="ltr"><span>Reprint requests to Dr. Lieberman, 566 First Avenue, New York, New York 10016.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>There was no history of congenital or rheumatic heart dis-</span></p>
<p dir="ltr"><span>ease, local neck trauma or infection, hypertension, diabetes</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>or hyperlipidemia. The patient was not taking oral contra-</span></p>
<p dir="ltr"><span>ceptives or any other medication. There was no family</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>history of heart disease, stroke, hypertension, or diabetes.</span></p>
<p dir="ltr"><span>On admission the temperature, pulse and respirations</span></p>
<p dir="ltr"><span>were normal. Blood pressure was 110 mm Hg by palpation</span></p>
<p dir="ltr"><span>on the right and unobtainable on the left. Examination of the</span></p>
<p dir="ltr"><span>lungs, heart and abdomen was normal. There were bilateral</span></p>
<p dir="ltr"><span>subclavian pulses but no axillary, brachial, or radial pulses.</span></p>
<p dir="ltr"><span>Carotid pulses were palpable and there were no bruits. There</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>were weak femoral pulses but none below the groin. All ex-</span></p>
<p dir="ltr"><span>tremities were pale and cold. Neurologically, the patient was</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>lethargic but arousable; she was confused and disoriented to</span></p>
<p dir="ltr"><span>time and place with a short attention span and exhibited</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>marked emotional lability; she was not aphasic. Examina-</span></p>
<p dir="ltr"><span>tion of the fundi was unremarkable. There was a dense left</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>homonymous hemianopia, a left hemisensory deficit, and a</span></p>
<p dir="ltr"><span>left hemiplegia (as marked in the arm as in the leg). There</span></p>
<p dir="ltr"><span>was a left Babinski sign without a reflex preponderance.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Hematocrit, hemoglobin, white blood cell count, differen-</span></p>
<p dir="ltr"><span>tial and platelet count were all normal. Sedimentation rate</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>was 12 mm per hour. Kaolin partial thromboplastin time</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>was slightly shortened and there was mild elevation of fac-</span></p>
<p dir="ltr"><span>tors II and V; otherwise, the coagulation profile was normal.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Sodium, potassium, chloride, CO2, calcium, phosphorus,</span></p>
<p dir="ltr"><span>total protein, albumin, direct and indirect bilirubin, alkaline</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>phosphatase, lactic dehydrogenase, creatinine phos-</span></p>
<p dir="ltr"><span>phokinase, uric acid, fasting blood sugar, two-hour post-</span></p>
<p dir="ltr"><span>prandial sugar, cholesterol, triglycerides, VDRL, T3, T4,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>serum and immune electrophoresis, antinuclear antibody</span></p>
<p dir="ltr"><span>and lupus preparations were all normal. Urinalysis revealed</span></p>
<p dir="ltr"><span>no protein or red cells. Skull films, chest x-ray, and flat plate</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>of the abdomen were normal. Electrocardiogram and echo-</span></p>
<p dir="ltr"><span>cardiogram were normal. Electroencephalogram (done one</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>day after admission) revealed 1.5 to 4 cycles per second</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Downloaded from http://ahajournals.org by on January 30, 2022</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>CEREBRAL MANIFESTATIONS OF ERGOTISM/Senter et al. 89</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>irregular slow waves bilaterally. Lumbar puncture revealed</span></p>
<p dir="ltr"><span>normal opening and closing pressures, no cells, and normal</span></p>
<p dir="ltr"><span>protein, glucose and gamma globulin. Computerized</span></p>
<p dir="ltr"><span>tomography (CT scan), with and without contrast, revealed</span></p>
<p dir="ltr"><span>large bifrontal areas of decreased absorption. There was no</span></p>
<p dir="ltr"><span>ventricular dilation or shift of midline structures (fig. 1).</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>The patient underwent cerebral angiography with selec-</span></p>
<p dir="ltr"><span>tive catheterization of both common carotids. Abrupt rat-</span></p>
<p dir="ltr"><span>tail tapering of the cervical portion of the right internal</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>carotid artery (ICA) was demonstrated. The artery was</span></p>
<p dir="ltr"><span>maximally narrowed at the level of C2-3 (fig. 2a) with the</span></p>
<p dir="ltr"><span>narrowing extending to involve the petrous, precavernous</span></p>
<p dir="ltr"><span>and cavernous portions of the vessel. Intracranially, an</span></p>
<p dir="ltr"><span>enlarged ophthalmic artery filled in a retrograde fashion</span></p>
<p dir="ltr"><span>from the external carotid and opacified the middle and</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>anterior cerebral arteries; it also filled the petrous, pre-</span></p>
<p dir="ltr"><span>cavernous and cavernous portions of the internal carotid</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>(fig. 2b). Cerebral circulation time was nine seconds. The left</span></p>
<p dir="ltr"><span>common carotid angiogram was a mirror image of the right</span></p>
<p dir="ltr"><span>(figs. 3a and b). Following the left common carotid injection,</span></p>
<p dir="ltr"><span>the patient had a transient right hemiparesis. Angiography</span></p>
<p dir="ltr"><span>was not continued.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Hospital Course</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Upon admission neither the physicians nor the husband</span></p>
<p dir="ltr"><span>were aware of the patient's daily use of ergotamine. On the</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>basis of the CT scan and the angiogram, a diagnosis of bi-</span></p>
<p dir="ltr"><span>frontal infarctions secondary to an arteritis was made and</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>the patient was begun on corticosteroids, methyl-</span></p>
<p dir="ltr"><span>prednisolone (Solumedrol&reg;) 40 mg intravenously every six</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>hours. The patient received a total of 160 mg of methyl-</span></p>
<p dir="ltr"><span>prednisolone during 24 hours. The patient was also anti-</span></p>
<p dir="ltr"><span>coagulated with heparin. The normal sedimentation rate and</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>negative ANA and LE preparations prompted several</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>physicians to raise the possibility of an iatrogenic (drug-</span></p>
<p dir="ltr"><span>induced) arteritis. Upon further questioning of the husband,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>the possibility of ergotism was strongly suggested and</span></p>
<p dir="ltr"><span>steroids and heparin were discontinued. Thirty-six hours</span></p>
<p dir="ltr"><span>later peripheral pulses in all four extremities returned. The</span></p>
<p dir="ltr"><span>hemiplegia, hemisensory defect and hemianopia resolved</span></p>
<p dir="ltr"><span>completely in ten days. At that time, the patient exhibited</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>inappropriate affect, short attention span and childlike un-</span></p>
<p dir="ltr"><span>FIGURE 1 Computerized tomographic scan showing large</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>confluent areas of decreased absorption (dark areas) viewed</span></p>
<p dir="ltr"><span>bilaterally from the frontal horns to the frontal poles. The ventricles</span></p>
<p dir="ltr"><span>are of normal size and are not displaced. There are no shifts of</span></p>
<p dir="ltr"><span>midline structures.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>2A</span></p>
<p dir="ltr"><span>FIGURE 2A Right common carotid angiogram: lateral projection,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>arterial phase, "neck series." The angiogram reveals abrupt "rat-</span></p>
<p dir="ltr"><span>tail" tapering of the cervical portion of the ICA at the level of the</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>C2 vertebral body (arrows). A high grade stenosis of the ICA is seen</span></p>
<p dir="ltr"><span>distal to the common carotid bifurcation.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Downloaded from http://ahajournals.org by on January 30, 2022</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>90 STROKE VOL. 7, No. 1, JANUARY-FEBRUARY 1976</span></p>
<p dir="ltr"><span>inhibited behavior. She complained of burning dysesthesias</span></p>
<p dir="ltr"><span>in both feet. Ten days after this, all signs and symptoms</span></p>
<p dir="ltr"><span>completely resolved.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Discussion</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>The ergot alkaloids have a number of effects on the</span></p>
<p dir="ltr"><span>vascular system, some mutually antagonistic. They are</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>direct vasoconstrictors, alpha adrenergic blockers, and cen-</span></p>
<p dir="ltr"><span>tral sympatholytics.1</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Their effectiveness as vasoconstrictors</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>is the basis of their use in the treatment of migraine. Struc-</span></p>
<p dir="ltr"><span>tural differences among the ergot alkaloids determine their</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>relative strength as vasoconstrictors, alpha blockers or cen-</span></p>
<p dir="ltr"><span>tral sympatholytics. Additionally, their effects in man de-</span></p>
<p dir="ltr"><span>pend upon differences in individual sensitivities and in the</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>sensitivity of the various vascular beds (cerebral, coronary,</span></p>
<p dir="ltr"><span>peripheral, renal, hepatic, mesenteric).1</span></p>
<p dir="ltr"><span>-</span></p>
<p dir="ltr"><span>2</span></p>
<p dir="ltr"><span>Furthermore, the</span></p>
<p dir="ltr"><span>route of administration may influence their effectiveness:</span></p>
<p dir="ltr"><span>Orally, the ergot alkaloids are irregularly absorbed from the</span></p>
<p dir="ltr"><span>small intestine; rectally, they are absorbed faster and attain</span></p>
<p dir="ltr"><span>higher blood levels. Ergot toxicity may be aggravated</span></p>
<p dir="ltr"><span>and/or precipitated by sepsis, hepatic or renal disease,</span></p>
<p dir="ltr"><span>thyrotoxicosis or pregnancy.3</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Specific drugs known to</span></p>
<p dir="ltr"><span>potentiate the effects of ergot are oral contraceptives* and</span></p>
<p dir="ltr"><span>certain antibiotics.5</span></p>
<p dir="ltr"><span>The toxic effects of the ergot alkaloids have been known</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>FIGURE 2B Right common carotid angiogram: lateral projection,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>mid-arterial phase, "head series." The angiogram demonstrates ex-</span></p>
<p dir="ltr"><span>cellent opacification of the ophthalmic artery which fills in a</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>retrograde fashion from external carotid-ophthalmic anastomoses.</span></p>
<p dir="ltr"><span>The supraclinoid, intracavernous, petrous and cervical, portions of</span></p>
<p dir="ltr"><span>the ICA also fill via the ophthalmic artery in a retrograde fashion</span></p>
<p dir="ltr"><span>(arrows). Poor opacification of the anterior cerebral and middle</span></p>
<p dir="ltr"><span>cereoral complexes is observed. Preferential external carotid flow is</span></p>
<p dir="ltr"><span>demonstrated.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>for a thousand years. Individuals who ingested rye con-</span></p>
<p dir="ltr"><span>taminated with the fungus Claviceps purpurea had</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>"epidemic ergotism" consisting of (1) gangrene of the ex-</span></p>
<p dir="ltr"><span>tremities, or (2) seizures, coma and dementia, or (3) a com-</span></p>
<p dir="ltr"><span>bination of the two. The gangrene was thought to be a result</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>of intense peripheral vasoconstriction while the seizures,</span></p>
<p dir="ltr"><span>coma and dementia were thought to result from either a</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>direct toxic effect on the CNS or intense cerebral vaso-</span></p>
<p dir="ltr"><span>constriction with subsequent hypoxia and infarction.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>The introduction of angiography enabled investigators to</span></p>
<p dir="ltr"><span>verify that the mechanism responsible for the toxic effects of</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>FIGURE 3A Left common carotid angiogram: lateral projection,</span></p>
<p dir="ltr"><span>arterial phase, "neck series." The angiogram demonstrates abrupt</span></p>
<p dir="ltr"><span>"rat-tail" narrowing of the cervical portion of the left ICA with</span></p>
<p dir="ltr"><span>preferential filling of the external carotid circulation, similar to that</span></p>
<p dir="ltr"><span>observed on the right side (arrows).</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Downloaded from http://ahajournals.org by on January 30, 2022</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>CEREBRAL MANIFESTATIONS OF ERGOTISM/Sen/er et al. m</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>ergot was intense vasoconstriction with secondary occlusion</span></p>
<p dir="ltr"><span>and thrombosis of medium and small arteries.5</span></p>
<p dir="ltr"><span>-</span></p>
<p dir="ltr"><span>6</span></p>
<p dir="ltr"><span>Most</span></p>
<p dir="ltr"><span>reports have stressed the effects of ergot on the peripheral</span></p>
<p dir="ltr"><span>vasculature.58</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>This effect is usually bilateral and sym-</span></p>
<p dir="ltr"><span>metrical, but both asymmetrical and unilateral vaso-</span></p>
<p dir="ltr"><span>constriction has been described.9</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Some reports have stressed</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>the multiplicity of vascular beds affected10</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>including the</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>mesenteric," renal,12</span></p>
<p dir="ltr"><span>coronary,13</span></p>
<p dir="ltr"><span>and ophthalmic.14</span></p>
<p dir="ltr"><span>Thus,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Merhoff and Porter2</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>described one patient with bilateral</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>peroneal nerve palsies (thought to be secondary to constric-</span></p>
<p dir="ltr"><span>tion of the vasonervorum) and one patient with transient</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>monocular blindness (thought to be secondary to vaso-</span></p>
<p dir="ltr"><span>constriction of the retinal arteries). Gupta and Strobos14</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>also</span></p>
<p dir="ltr"><span>reported a patient with bilateral amblyopia. They reviewed</span></p>
<p dir="ltr"><span>the literature on the ophthalmological complications of</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>ergotism and concluded that ischemia occurred at a water-</span></p>
<p dir="ltr"><span>shed zone between the peripheral and axial vasculature of</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>the optic nerve. Most of these patients were not septic and</span></p>
<p dir="ltr"><span>did not have renal or hepatic dysfunction.</span></p>
<p dir="ltr"><span>Cerebral manifestations of nonepidemic ergotism have</span></p>
<p dir="ltr"><span>been less frequently described and rarely has the underlying</span></p>
<p dir="ltr"><span>mechanism been documented. Thus, although Hudgson and</span></p>
<p dir="ltr"><span>Hart15</span></p>
<p dir="ltr"><span>described a patient who, after taking 30 Cafergot</span></p>
<p dir="ltr"><span>tablets, went into coma without lateralizing findings and</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>without pulses below the groin, the mechanism of the</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>cerebral symptoms remains speculative because angi-</span></p>
<p dir="ltr"><span>ography had not been performed. The symptoms could</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>represent a direct toxic effect of ergot on the brain or diffuse</span></p>
<p dir="ltr"><span>cerebral vasoconstriction. Adequate documentation of the</span></p>
<p dir="ltr"><span>mechanism responsible for some of the cerebral</span></p>
<p dir="ltr"><span>manifestations is found in the reports of Brohult, Forsberg</span></p>
<p dir="ltr"><span>and Hellstrom4</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>and of Richter and Banker.16</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Brohult et al.4</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>described a patient who had signs of diffuse cerebral dys-</span></p>
<p dir="ltr"><span>function (confusion) in addition to a left hemiparesis. Angi-</span></p>
<p dir="ltr"><span>ography revealed occlusion of the right internal carotid</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>artery. Thus, while the mechanism underlying the right</span></p>
<p dir="ltr"><span>cerebral dysfunction is known, the mechanism underlying</span></p>
<p dir="ltr"><span>the diffuse dysfunction is not. Richter and Banker16</span></p>
<p dir="ltr"><span>reported</span></p>
<p dir="ltr"><span>a patient with a minimal left facial palsy, hypalgesia of the</span></p>
<p dir="ltr"><span>left arm, and nystagmus on right lateral gaze. These findings</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>were interpreted as being consistent with right cerebral dys-</span></p>
<p dir="ltr"><span>function (omitting the nystagmus). Angiography revealed</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>marked "rat-tail" narrowing of the distal right internal</span></p>
<p dir="ltr"><span>carotid artery at the base of the neck.</span></p>
<p dir="ltr"><span>Our patient presented with signs of both diffuse and right</span></p>
<p dir="ltr"><span>cerebral dysfunction. The mechanism for both was revealed</span></p>
<p dir="ltr"><span>to be vasoconstriction with bifrontal infarction. Our failure</span></p>
<p dir="ltr"><span>to promptly recognize the cerebral symptoms as being due</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>^</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>{ .</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>FIGURE 3B Left common carotid angiogram: lateral projection, mid-arterial phase, "head series." The</span></p>
<p dir="ltr"><span>angiogram demonstrates retrograde filling of the ophthalmic artery which then opacifies the supraclinoid,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>intracavernous, and petrous portions of the ICA farrows), and the middle cerebral complex. No opacifica-</span></p>
<p dir="ltr"><span>tion of the anterior cerebral artery is seen.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Downloaded from http://ahajournals.org by on January 30, 2022</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>92 STROKE VOL. 7, No. 1, JANUARY-FEBRUARY 1976</span></p>
<p dir="ltr"><span>TABLE 1 Neurological Manifestations of Ergotism</span></p>
<p dir="ltr"><span>Neurological deficit Site of vascular disease Dose of ergotaraine</span></p>
<p dir="ltr"><span>Coma15</span></p>
<p dir="ltr"><span>Diffuse cortical</span></p>
<p dir="ltr"><span>Uninhibited Bifrontal</span></p>
<p dir="ltr"><span>behavior*</span></p>
<p dir="ltr"><span>Hemiparesis/ Internal carotid</span></p>
<p dir="ltr"><span>hemianopia*</span></p>
<p dir="ltr"><span>Amaurosis2</span></p>
<p dir="ltr"><span>Retinal artery</span></p>
<p dir="ltr"><span>Papillitis" Optic nerve ischemia Peroneal nerve Vasonervorum</span></p>
<p dir="ltr"><span>palsy2</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>30 mg, single dose 1 mg/day, rectally</span></p>
<p dir="ltr"><span>1 mg/day, rectally</span></p>
<p dir="ltr"><span>4-6 mg/day, rectally</span></p>
<p dir="ltr"><span>6-8 mg/day, orally</span></p>
<p dir="ltr"><span>4 mg/day, rectally</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>*This patient.</span></p>
<p dir="ltr"><span>to ergotism was related to the rarity of this presentation. In</span></p>
<p dir="ltr"><span>retrospect the occurrence of diffuse and focal (right) cerebral</span></p>
<p dir="ltr"><span>dysfunction associated with absent peripheral pulses in a</span></p>
<p dir="ltr"><span>young person with angiographical evidence of an arteritis</span></p>
<p dir="ltr"><span>but without laboratory confirmation should have raised the</span></p>
<p dir="ltr"><span>possibility of an iatrogenic etiology. If the patient's history</span></p>
<p dir="ltr"><span>was accurate, then the arteritis occurred with a dosage of</span></p>
<p dir="ltr"><span>ergot which is well below the maximum recommended</span></p>
<p dir="ltr"><span>dosage. The patient had been on no more than 1 mg per day</span></p>
<p dir="ltr"><span>(rectally) for three weeks, 7 mg per week. The maximum</span></p>
<p dir="ltr"><span>recommended dosage is 8 mg per week (rectally). Moreover,</span></p>
<p dir="ltr"><span>she had used the drug safely for 20 years. Either the patient's</span></p>
<p dir="ltr"><span>symptoms were due to a cumulative effect of the drug or she</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>took more of the drug than she remembers. Table 1 sum-</span></p>
<p dir="ltr"><span>marizes some of the recorded cases of neurological dys-</span></p>
<p dir="ltr"><span>function occurring during ergot therapy and correlates them</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>with the dosage at which they occurred.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>Lastly, with regard to treatment, various procedures in-</span></p>
<p dir="ltr"><span>cluding sympathetic blockade, vasodilating agents, corti-</span></p>
<p dir="ltr"><span>costeroids and anticoagulants have been employed without</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>success. In our patient a vasodilating agent, corticosteroids,</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>and anticoagulants did not alter the course of the dys-</span></p>
<p dir="ltr"><span>function. As ergotism is self-limiting, the best treatment is</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>prompt recognition and withdrawal of the drug.</span></p>
<p dir="ltr"><span>Acknowledgment</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>The authors wish to thank Drs. Morton Leibowitz, Abraham Sunshine,</span></p>
<p dir="ltr"><span>Frank C. Spencer, Joseph Cunningham and Al Culliford for their invaluable</span></p>
<p dir="ltr"><span>help in diagnosis and treatment; Drs. Bennett Derby, William K. Hass and</span></p>
<p dir="ltr"><span>Clark T. Randt for reviewing the manuscript; and Ms. Kathleen Faridazar</span></p>
<p dir="ltr"><span>for typing the manuscript.</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>References</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>1. Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics.</span></p>
<p dir="ltr"><span>Fourth edition. New York, Macmillan Co, pp 557-559, 897-905, 1970</span></p>
<p dir="ltr"><span>2. Merhoff GC, Porter JM: Ergot intoxication: Historical review and</span></p>
<p dir="ltr"><span>description. Ann Surg 180:773-779, 1974</span></p>
<p dir="ltr"><span>3. Enge I, Sivertssen E: Ergotism due to therapeutic doses of ergotamine.</span></p>
<p dir="ltr"><span>Am Heart J 70:665-670, 1965</span></p>
<p dir="ltr"><span>4. Brohult J, Forsberg O, Hellstrom R: Multiple arterial thrombosis after</span></p>
<p dir="ltr"><span>oral contraceptives and ergotamine. Acta Med Scand 181:453-456, 1967</span></p>
<p dir="ltr"><span>5. Bagby RJ, Cooper RD: Angiography in ergotism. Am J Roentgenol Rad</span></p>
<p dir="ltr"><span>Ther Nucl Med 116:179-186, 1972</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>6. Yater WM, Cahill JA: Bilateral gangrene of feet due to ergotamine tar-</span></p>
<p dir="ltr"><span>trate used for pruritus of jaundice. JAMA 106:1625-1631, 1936</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>7. Pader E: Leriche syndrome in a patient with prolonged and continuous</span></p>
<p dir="ltr"><span>use of ergot derivatives. Vase Dis 4:380-388, 1967</span></p>
<p dir="ltr"><span>8. Huel J, Mune O: Peripheral arterial insufficiency in ergotism. Vase Dis 4:</span></p>
<p dir="ltr"><span>159-166, 1967</span></p>
<p dir="ltr"><span>9. Tator CH, Heimbecker RO: Unilateral arm ischemia due to ergotamine</span></p>
<p dir="ltr"><span>tartrate. Canad Med Assoc J 95:1319-1321, 1966</span></p>
<p dir="ltr"><span>10. Hemingway DL: Ergot poisoning with multisystem involvement. Milit</span></p>
<p dir="ltr"><span>Med 130:1103-1104, 1965</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>11. Holmes G, Martin E, Tuba S: Mesenteric vascular occlusion in pregnan-</span></p>
<p dir="ltr"><span>cy: Suspected ergot poisoning. Med J Aust 2:1009-1011, 1969</span></p>
<p><span><span>&nbsp;</span></span></p>
<p dir="ltr"><span>12. Fedotin MS, Hartman C: Ergotamine poisoning producing renal arterial</span></p>
<p dir="ltr"><span>spasm. New Eng J Med 283:518-520, 1970</span></p>
<p dir="ltr"><span>13. Goldfischer JD: Acute myocardial infarction secondary to ergot therapy.</span></p>
<p dir="ltr"><span>New Eng J Med 262:860-863, I960</span></p>
<p dir="ltr"><span>14. Gupta DR, Strobos RJ: Bilateral papillitis associated with Cafergot*</span></p>
<p dir="ltr"><span>therapy. Neurology 22:793-797 (Aug) 1972</span></p>
<p dir="ltr"><span>15. Hudgson P, Hart JA: Acute ergotism. Med J Aust 2:589-591, 1964</span></p>
<p dir="ltr"><span>16. Richter AM, Banker VP: Carotid ergotism. Radiology 106:339-340,</span></p>
<p dir="ltr"><span>1973</span></p>
    </body> 
</html> 